Ferraz-Amaro, I <br/><br/>
Systemic blockade of TNF-α does not improve insulin resistance in humans.  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  Oct 2011 
 - 801-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-4286 
<br/><br/><label>Standard No.: </label>10.1055/s-0031-1287783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Anabolic Agents--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Cohort Studies<br/>Etanercept<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>Insulin Resistance<br/>Male<br/>Metabolic Syndrome--drug therapy<br/>Middle Aged<br/>Prospective Studies<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Reproducibility of Results<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors